p90/CIP2A mediates breast cancer cell proliferation and apoptosis |
| |
Authors: | Xinxin Liu Bo Peng Yang Li Ningjing Lei Wenjie Li Jian-Ying Zhang |
| |
Affiliation: | 1. Department of Biology Sciences, The University of Texas at El Paso, El Paso, TX, 79968, USA 2. College of Public Health, Zhengzhou University, Zhengzhou, 450001, Henan, China
|
| |
Abstract: | Cancerous inhibitor of PP2A (p90/CIP2A) was recently characterized as an innovative oncoprotein in human malignancies. p90/CIP2A inhibited c-Myc-associated PP2A phosphatase activity to promote cell proliferation and tumor growth. A growing number of studies have demonstrated that the overexpression of p90/CIP2A in various human malignancies. But the function of p90/CIP2A in cancer progression is still poorly understood. In the current research, we aim to explore the biological function of p90/CIP2A in breast cancer. shRNA knockdown was performed in MDA-MB-231 and LM2-4 cell lines. Cell proliferation assay, colony formation assay and flow cytometry were carried out to evaluate the role of p90/CIP2A in cell proliferation and apoptosis. p90/CIP2A depletion in breast cancer cells inhibited proliferation and increased paclitaxel-induced apoptosis. Furthermore, p90/CIP2A silencing down-regulated the expression of c-Myc and the level of p-ERK1/2. Taken together, our data suggest that p90/CIP2A as a crucial oncoprotein has been involved in cell proliferation and apoptosis, which may serve as a therapeutic target in breast cancer treatment. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|